Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.

[1]  J. Sundquist,et al.  Identification of Genetic Aberrations in Thrombomodulin Gene in Patients With Recurrent Venous Thromboembolism , 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  S. Sebert,et al.  Fto-Deficiency Affects the Gene and MicroRNA Expression Involved in Brown Adipogenesis and Browning of White Adipose Tissue in Mice , 2016, International journal of molecular sciences.

[3]  B. Dahlbäck,et al.  Epidemiology of Familial Aggregation of Venous Thromboembolism , 2016, Seminars in Thrombosis and Hemostasis.

[4]  Richard D Riley,et al.  University of Birmingham A systematic review of prognostic models for recurrent venous thromboembolism (VTE) post treatment of first unprovoked VTE , 2016 .

[5]  L. Orozco,et al.  Gender-Dependent Association of FTO Polymorphisms with Body Mass Index in Mexicans , 2016, PloS one.

[6]  J. Fahrni,et al.  Assessing the risk of recurrent venous thromboembolism – a practical approach , 2015, Vascular health and risk management.

[7]  J. Heit.  Epidemiology of venous thromboembolism , 2015, Nature Reviews Cardiology.

[8]  M. Benn,et al.  Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study , 2015, Journal of internal medicine.

[9]  S. Hannenhalli,et al.  Conservation in first introns is positively associated with the number of exons within genes and the presence of regulatory epigenetic signals , 2014, BMC Genomics.

[10]  J. Mi,et al.  Age- and Sex-Dependent Association between FTO rs9939609 and Obesity-Related Traits in Chinese Children and Adolescents , 2014, PloS one.

[11]  P. Mannucci,et al.  Inherited risk factors for venous thromboembolism , 2014, Nature Reviews Cardiology.

[12]  S. Cannegieter,et al.  Venous thrombosis: understanding the paradoxes of recurrence , 2013, Journal of thrombosis and haemostasis : JTH.

[13]  H. Kluin-Nelemans,et al.  Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study , 2012, British journal of haematology.

[14]  A. Gottsäter,et al.  Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form. , 2012, Thrombosis research.

[15]  Nirav R. Shah,et al.  Measuring Adiposity in Patients: The Utility of Body Mass Index (BMI), Percent Body Fat, and Leptin , 2012, PloS one.

[16]  M. Donati,et al.  Thrombosis and obesity: cellular bases. , 2012, Thrombosis research.

[17]  A. Ciampi,et al.  Men had a higher risk of recurrent venous thromboembolism than women: a large population study. , 2012, Gender medicine.

[18]  J. Sundquist,et al.  Age- and Gender-Specific Familial Risks for Venous ThromboembolismClinical Perspective , 2011 .

[19]  F. Rosendaal,et al.  Risk assessment for recurrent venous thrombosis , 2010, The Lancet.

[20]  A. Iorio,et al.  Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. , 2010, Archives of internal medicine.

[21]  Roger D. Cox,et al.  Overexpression of Fto leads to increased food intake and results in obesity , 2010, Nature Genetics.

[22]  J. Pitha,et al.  A FTO variant and risk of acute coronary syndrome. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[23]  P. Wells,et al.  Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism , 2010, Annals of Internal Medicine.

[24]  T. Baglin,et al.  Unraveling the thrombophilia paradox: from hypercoagulability to the prothrombotic state , 2010, Journal of thrombosis and haemostasis : JTH.

[25]  L. Lannfelt,et al.  The common FTO variant rs9939609 is not associated with BMI in a longitudinal study on a cohort of Swedish men born 1920-1924 , 2009, BMC Medical Genetics.

[26]  S. Yanovski,et al.  The FTO gene rs9939609 obesity-risk allele and loss of control over eating. , 2009, The American journal of clinical nutrition.

[27]  A. Gottsäter,et al.  Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS). , 2009, Thrombosis research.

[28]  A. Folsom,et al.  C-reactive protein and venous thromboembolism , 2009, Thrombosis and Haemostasis.

[29]  M. Prins,et al.  A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. , 2009, Blood.

[30]  D. Allison,et al.  Mortality, Health Outcomes, and Body Mass Index in the Overweight Range: A Science Advisory From the American Heart Association , 2009, Circulation.

[31]  Jens C. Brüning,et al.  Inactivation of the Fto gene protects from obesity , 2009, Nature.

[32]  M. Schulze,et al.  Association of the FTO rs9939609 Single Nucleotide Polymorphism With C‐reactive Protein Levels , 2009, Obesity.

[33]  Tom R. Gaunt,et al.  American Journal of Epidemiology Practice of Epidemiology Hardy-weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies , 2022 .

[34]  J. Heit,et al.  The epidemiology of venous thromboembolism in the community. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[35]  J. Douketis,et al.  The Risk for Fatal Pulmonary Embolism after Discontinuing Anticoagulant Therapy for Venous Thromboembolism , 2007, Annals of Internal Medicine.

[36]  Cecilia Becattini,et al.  Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis , 2008, Circulation.

[37]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[38]  D. Hunter.  Gene–environment interactions in human diseases , 2005, Nature Reviews Genetics.

[39]  T. Baglin,et al.  High risk of recurrent venous thromboembolism in men , 2004, Journal of thrombosis and haemostasis : JTH.

[40]  E. Minar,et al.  The risk of recurrent venous thromboembolism in men and women. , 2004, The New England journal of medicine.

[41]  M. de Andrade,et al.  Familial segregation of venous thromboembolism , 2004, Journal of thrombosis and haemostasis : JTH.

[42]  J. Vaupel,et al.  Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins , 2003, Epidemiology.

[43]  D. Allison,et al.  Twins and virtual twins: bases of relative body weight revisited , 2002, International Journal of Obesity.

[44]  J. Stephens,et al.  Haplotype Variation and Linkage Disequilibrium in 313 Human Genes , 2001, Science.

[45]  M Gent,et al.  A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. , 1999, The New England journal of medicine.

[46]  B. Dahlbäck,et al.  A New Direct, Fast and Quantitative Enzyme-linked Ligandsorbent Assay for Measurement of Free Protein S Antigen , 1998, Thrombosis and Haemostasis.

[47]  M. Neale,et al.  Genetic and Environmental Factors in Relative Body Weight and Human Adiposity , 1997, Behavior genetics.

[48]  B. Dahlbäck,et al.  Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries , 1996, Journal of internal medicine.

[49]  D. Cooper,et al.  Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency. , 1995, Journal of medical genetics.

[50]  R. Francis,et al.  Rapid amidolytic assay of protein C in whole plasma using an activator from the venom of Agkistrodon contortrix. , 1987, American journal of clinical pathology.

[51]  O. Odegård,et al.  Heparin cofactor activity measured with an amidolytic method. , 1975, Thrombosis research.

[52]  J. Sundquist,et al.  A sibling based design to quantify genetic and shared environmental effects of venous thromboembolism in Sweden. , 2017, Thrombosis research.

[53]  R. Loos,et al.  The bigger picture of FTO—the first GWAS-identified obesity gene , 2014, Nature Reviews Endocrinology.

[54]  M. Patlas,et al.  The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. , 2012, The British journal of radiology.

[55]  Christian Gieger,et al.  Six new loci associated with body mass index highlight a neuronal influence on body weight regulation , 2009, Nature Genetics.

[56]  W. Ageno,et al.  Abdominal obesity and the risk of recurrent deep vein thrombosis. , 2007, Thrombosis research.

[57]  E. Minar,et al.  The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene , 1999, Thrombosis and Haemostasis.